Fate Therapeutics Stock Signals
Latest Data & Signals Issued
| Signal Type | Signal Value | Data | |
|---|---|---|---|
| Score | -4.039 | 21 days ( 15.54 % ) | |
| Last Price | $2.12 | -2.75 % | |
| High/ Low | $2.11 - $2.24 | 6.64% | |
| Chg 7 Days | 0.474 % | $2.11 $2.12 | |
| Chg 30 Days | -19.70 % | $2.64 $2.12 | |
| Chg 12 mos | -90.51 % | $22.34 $2.12 | |
| Trend - 3 mos | -60.37 % | Width: 36.36 % | |
| Trend - 12 mos | -73.75 % | Width: 284.80 % | |
| Pred. range - 3 mos | $0.619 - $0.84 | -70.82 % - -60.21 % | |
| Pred. range - 12 mos | N/A - $1.76 | -100.00 % - -17.09 % | |
| Short mv avg 3 mos | Buy | 2023-09-27 - 3 days | |
| Long mv avg 3 mos | Sell | 0000-00-00 - N/A days | |
| Short/Long mv avg 3 mos | Sell | 0000-00-00 - N/A days | |
| Short mv avg 12 mos | Sell | 2023-06-21 - 71 days | |
| Long mv avg 12 mos | Sell | 2023-06-21 - 71 days | |
| Short/Long mv avg 12 mos | Sell | 0000-00-00 - N/A days | |
| Pivot Short | Buy | 2023-09-26 - 4 days | |
| Bollinger | Buy | 2023-09-15 - 11 days | |
| MACD | Sell | No Dates Stored For This Signal |
Signals Effectiveness
Backtesting is not only a way to check stock signal accuracy, but also a tool to continually improvement. Data can be used for self adjustment as each stock has an individual behavior.
Accuracy and return is not the same. A stock signal may provide low statistical accuracy, but the signals may prove high return in average.
Sharp market dips or fundamental changes (earning reports, news updates etc), may force a short term reaction and disturb the signals (Signals may jump quickly from buy to sell, just to return to buy).
Stock Score
Bollinger Bands
MACD
Moving Average (7d)
About Fate Therapeutics
Fate Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops programmed cellular immunotherapies for cancer and immune disorders worldwide. Its NK- and T-cell immuno-oncology programs under development include FT516 for the treatment of acute myeloid leukemia (AML) B-cell lymphoma, and advanced solid tumor; FT596 to treat B-cell lymphoma and chronic lymphocytic leukemia; FT538 to treat AML and multiple myeloma; FT576 to treat mul... FATE Profile
Top Fintech Company
featured in The Global Fintech Index 2020 as the top Fintech company of the country.
